FDA Flags Missing Trial Results - Takeaway - MDSpire
FDA & Government News

FDA Flags Missing Trial Results

Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available

Share

  • 1

    FDA sent reminders to 2,200 companies about reporting trial results.

  • 2

    29.6% of required studies had no results posted.

  • 3

    Excludes phase 1 trials and device feasibility studies.

  • 4

    Results must be submitted within 1 year of completion.

  • 5

    Gaps in reporting can lead to publication bias.

  • 6

    Correspondence aims for voluntary compliance before enforcement.

  • 7

    Importance of transparency emphasized by FDA officials.

Original Source(s)

FDA Flags Missing Trial Results

  • by Kathryn Wighton

  • April 13, 2026

Related Content

Can Nasal Nitric Oxide Aid PCD Diagnosis?

Evidence synthesis shows strong diagnostic performance but highlights variability across subgroups and clinical settings

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Utah Just Let an Algorithm Write Prescriptions

Physician oversight waived in state sandbox; federal review status unclear